McCormick & Company
MKC
$51.78
-3.12%
McCormick & Company is the world's leading manufacturer of spices, herbs, extracts, seasonings, and flavorings, operating in the packaged foods industry. Its portfolio includes iconic brands such as Old Bay, Frank's RedHot, French's, and Cholula, giving it a dominant position in the global flavor market. The current investor narrative centers on the transformative $45 billion acquisition of Unilever's food business (including Knorr and Hellmann's), which has sparked intense debate about integration risks, debt load, and long-term growth potential. Recent news highlights skepticism over the deal's execution, causing the stock to plunge to 52-week lows despite solid quarterly earnings.…
MKC
McCormick & Company
$51.78
Related headlines
Investment Opinion: Should I buy MKC Today?
Rating: Hold. The thesis is that McCormick's transformative Unilever acquisition offers significant long-term upside, but near-term integration risks and margin pressure warrant caution. The analyst consensus is neutral, with an average EPS estimate of $4.63 for the next fiscal year, implying a forward P/E of 11.5x at the current price, which suggests substantial upside if the deal succeeds.
Supporting evidence: (1) Forward P/E of 16.2x is below the industry average of 20x and McCormick's historical range of 20-35x. (2) Revenue growth accelerated to 16.7% YoY in Q1 2026, driven by the pending acquisition. (3) Free cash flow of $851 million provides a cushion for debt service and dividends. (4) The dividend yield of 2.7% is supported by a 61.2% payout ratio. However, the trailing P/E of 22.6x is above the industry average, reflecting the market's skepticism about near-term earnings quality.
Risks & Conditions: The biggest risks are integration failure of the Unilever deal, margin compression from higher leverage, and limited analyst coverage leading to volatility. This Hold would upgrade to Buy if the stock falls below $45 (near 52-week low) or if the deal closes with clear synergy targets. It would downgrade to Sell if operating margins fall below 10% or if revenue growth decelerates below 5% post-deal. Valuation verdict: The stock appears undervalued on a forward basis but fairly valued on trailing metrics, reflecting the market's uncertainty about the deal's outcome.
Sign up to view all
MKC 12-Month Price Forecast
McCormick is at a pivotal juncture with the Unilever acquisition. The forward valuation is attractive, but the stock's 30% decline and limited analyst coverage reflect deep skepticism. The base case of a successful but messy integration is most likely, with the stock trading in a $50-60 range. A bullish outcome would require flawless execution and clear synergy realization, while a bearish outcome could see the stock test $40. The neutral stance is driven by the balanced risk/reward: the potential upside from the deal is offset by significant execution risk. Upgrades would come from evidence of margin recovery and deal synergies; downgrades from integration failures or regulatory hurdles.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on McCormick & Company's 12-month outlook, with a consensus price target around $67.31 and implied upside of +30.0% versus the current price.
Average Target
$67.31
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$41 - $67
Analyst target range
Only 4 analysts cover McCormick, indicating limited institutional interest. The consensus recommendation is neutral, with a mix of ratings: Barclays and UBS rate it Equal Weight/Neutral, while Deutsche Bank and JP Morgan rate it Buy/Overweight. The average estimated EPS for the next fiscal year is $4.63, with a range of $4.55 to $4.70. The average revenue estimate is $8.84 billion, with a range of $8.72 billion to $8.94 billion. No explicit price targets are provided, but the EPS estimates imply a forward P/E of 11.5x at the current price, suggesting significant upside if the company meets expectations. The limited analyst coverage means less efficient price discovery and potentially higher volatility. The wide range in revenue estimates ($8.72B to $8.94B) reflects uncertainty around the Unilever deal's closing and integration. The consensus leans cautiously optimistic, but the small number of analysts means the stock may be overlooked by the broader market.
Bulls vs Bears: MKC Investment Factors
McCormick presents a high-risk, high-reward opportunity centered on the transformative Unilever acquisition. The bull case rests on the potential for the deal to triple the business, accelerate revenue growth, and create a global flavor leader with strong emerging market exposure. The forward P/E of 16.2x is attractive relative to history and peers. However, the bear case highlights massive integration risk, a 30% stock decline over the past year, and margin compression from deal costs. The single most important tension is whether management can successfully integrate Unilever's food business without significant earnings dilution or operational disruption. Currently, the bearish evidence (stock price action, margin pressure, limited analyst support) outweighs the bullish potential, making this a speculative investment for patient, risk-tolerant investors.
Bullish
- Transformative Unilever acquisition: The $45 billion acquisition of Unilever's food business (Knorr, Hellmann's) is expected to create a $20 billion flavor giant, with 70% consumer sales and 40% emerging market exposure. This could triple the business and unlock significant cost synergies.
- Revenue growth accelerating: Q1 2026 revenue grew 16.7% YoY to $1.874 billion, accelerating from 2.9% in Q4 2025 and 2.7% in Q3 2025. This momentum is partly driven by the pending acquisition, which is expected to boost top-line growth further.
- Strong free cash flow generation: Trailing twelve-month free cash flow is $851 million, providing a solid base for debt repayment and dividend growth. The dividend yield of 2.7% is supported by a payout ratio of 61.2%, offering income stability.
- Attractive forward valuation: The forward P/E of 16.2x is a discount to the packaged foods industry average of ~20x and below McCormick's historical range of 20-35x. This implies the market is pricing in significant skepticism, creating a potential value opportunity.
Bearish
- Massive integration risk: The $45 billion Unilever acquisition is highly complex and debt-financed, with the debt-to-equity ratio expected to rise from 0.70. Integration failures could lead to margin compression and earnings dilution, as seen in the Q1 2026 operating margin drop to 12.1% from 17.1% in Q4 2025.
- Stock in sustained downtrend: MKC has declined 30.2% over the past year, trading near its 52-week low of $44.82. The stock is down 20.6% year-to-date, reflecting persistent investor skepticism about the deal's execution.
- Limited analyst coverage: Only 4 analysts cover MKC, with a neutral consensus. This limited coverage means less efficient price discovery and potentially higher volatility, as the stock may be overlooked by institutional investors.
- Margin pressure from deal costs: Operating margin fell to 12.1% in Q1 2026 from 17.1% in Q4 2025, partly due to deal-related costs. Gross margin of 37.8% is stable but could face pressure from integration expenses and higher leverage.
MKC Technical Analysis
McCormick is in a sustained downtrend, with the stock declining 30.2% over the past year. The current price of $53.45 sits at 71.3% of its 52-week range (low $44.82, high $74.95), indicating it is closer to the bottom than the top. This positioning near the low end suggests the market is pricing in significant uncertainty, but also presents a potential value opportunity if the turnaround thesis materializes. Short-term momentum shows a sharp recovery, with the stock up 15.8% over the past month and 9.4% over the past three months, diverging sharply from the one-year downtrend. This divergence could signal a potential trend reversal or a temporary relief rally, especially given the relative strength of +17.1% versus the S&P 500 over the past month. The stock's beta of 0.626 indicates it is less volatile than the market, which may appeal to risk-averse investors but also limits upside in a broad rally. Key support lies at the 52-week low of $44.82, while resistance is at the 52-week high of $74.95. A breakout above $74.95 would signal a major reversal, while a breakdown below $44.82 could accelerate selling pressure. The low beta suggests the stock may not participate fully in a market rally, but also offers downside protection during corrections.
Beta
0.63
0.63x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$45-$75
Price range past year
Annual Return
-31.1%
Cumulative gain past year
| Period | MKC Return | S&P 500 |
|---|---|---|
| 1m | +9.6% | +1.9% |
| 3m | +1.5% | +14.0% |
| 6m | -20.8% | +8.9% |
| 1y | -31.1% | +20.1% |
| ytd | -23.0% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKC Fundamental Analysis
Revenue has been growing steadily, with the most recent quarter (Q1 2026) reporting $1.874 billion, up 16.7% year-over-year from $1.605 billion in Q1 2025. The multi-quarter trend shows accelerating growth: Q1 2026's 16.7% YoY increase compares favorably to Q4 2025's 2.9% growth and Q3 2025's 2.7% growth. The Consumer segment contributed $1.145 billion and Flavor Solutions $729 million, with both segments driving the top line. This acceleration is partly due to the pending Unilever acquisition, which is expected to significantly boost revenue but also adds integration risk. Profitability is strong, with net income of $1.016 billion in Q1 2026, representing a net margin of 54.2% (boosted by a one-time gain from the Unilever deal). Excluding that, normalized net income was likely lower. Gross margin was 37.8%, relatively stable compared to 37.6% in Q1 2025 and 38.9% in Q4 2025. Operating margin was 12.1%, down from 17.1% in Q4 2025, indicating some margin compression due to deal-related costs. The company remains profitable with a trailing twelve-month net income of $1.016 billion, but the high net margin in Q1 is not sustainable. The balance sheet shows a debt-to-equity ratio of 0.70, manageable but expected to rise after the Unilever acquisition. Free cash flow for the trailing twelve months was $851 million, providing solid cash generation. The current ratio of 0.70 indicates tight liquidity, but the company has access to capital markets. ROE of 13.8% is healthy, though it may decline if the acquisition is debt-financed. Overall, the company has strong cash flow but will need to manage leverage carefully post-deal.
Quarterly Revenue
$1.9B
2026-02
Revenue YoY Growth
+0.16%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$851000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKC Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 22.6x, while the forward P/E is 16.2x, implying the market expects earnings growth from the Unilever acquisition. The gap between trailing and forward P/E suggests the market is pricing in a significant earnings uplift, which is optimistic given the integration risks. Compared to the packaged foods industry average P/E of approximately 20x (based on sector data), McCormick's trailing P/E of 22.6x represents a 13% premium. This premium may be justified by its strong brand portfolio and market leadership, but the forward P/E of 16.2x is actually a discount to the industry average, reflecting skepticism about the deal's near-term benefits. Historically, McCormick's trailing P/E has ranged from 20x to 35x over the past five years. The current 22.6x is near the lower end of that range, suggesting the stock is relatively cheap compared to its own history. This could indicate a value opportunity if the company successfully integrates Unilever's food business and returns to historical growth rates. However, the low P/E also reflects the market's concerns about execution risk and potential dilution.
PE
22.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 5x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: McCormick's debt-to-equity ratio of 0.70 is manageable but expected to rise significantly after the $45 billion Unilever acquisition, increasing interest expense and financial leverage. The current ratio of 0.70 indicates tight liquidity, though the company generates $851 million in free cash flow. Operating margin compressed to 12.1% in Q1 2026 from 17.1% in Q4 2025, signaling deal-related cost pressures. Revenue concentration in the Consumer segment (61% of Q1 2026 sales) adds vulnerability to shifts in consumer spending. The high net margin of 54.2% in Q1 2026 was boosted by a one-time gain and is not sustainable, with normalized net margins likely around 10-12%.
Market & Competitive Risks: The stock's beta of 0.626 suggests lower market correlation, but the 30.2% decline over the past year indicates company-specific risk dominates. The forward P/E of 16.2x is a discount to the industry average of 20x, but this could compress further if the deal fails to deliver expected synergies. Competitive threats from private-label brands and other packaged food giants (e.g., Kraft Heinz, Nestlé) could pressure margins. Regulatory risks include antitrust scrutiny of the Unilever deal, which could delay or block the acquisition. Recent news highlights skepticism from analysts and media, with the stock plunging to 52-week lows despite solid earnings.
Worst-Case Scenario: If the Unilever acquisition fails to close or integration proves disastrous, MKC could fall to its 52-week low of $44.82, representing a 16% downside from the current price of $53.45. In a severe recession with margin compression and debt distress, the stock could test the historical max drawdown of -41.2%, implying a potential loss of 41% to around $31.50. This scenario would require a combination of failed deal execution, rising interest rates, and a consumer spending downturn.
FAQ
The primary risk is integration failure of the $45 billion Unilever acquisition, which could lead to margin compression, earnings dilution, and a debt downgrade. Financial risks include a debt-to-equity ratio of 0.70 that will rise post-deal, and a current ratio of 0.70 indicating tight liquidity. Market risks include the stock's 30.2% decline over the past year and limited analyst coverage (only 4 analysts), which can lead to higher volatility. Company-specific risks include potential antitrust challenges to the deal and a reliance on consumer spending for 61% of revenue. The most severe risk is a worst-case scenario where the stock falls to $40 or below, representing a 25% downside from current levels.
The 12-month outlook is mixed. The bull case (25% probability) sees the stock reaching $65-75 if the Unilever deal closes smoothly with strong synergies. The base case (50% probability) expects the stock to trade in a $50-60 range as integration progresses but with challenges. The bear case (25% probability) could see the stock fall to $40-48 if the deal fails or integration costs spiral. The average analyst EPS estimate of $4.63 implies a forward P/E of 11.5x at the current price, suggesting significant upside if the company meets expectations. However, the neutral analyst consensus and limited coverage indicate uncertainty. The most likely scenario is the base case, with the stock trading around $55 in 12 months.
MKC appears undervalued on a forward basis but fairly valued on trailing metrics. The forward P/E of 16.2x is a 19% discount to the packaged foods industry average of 20x and well below McCormick's historical range of 20-35x. However, the trailing P/E of 22.6x is slightly above the industry average, reflecting the market's skepticism about near-term earnings quality due to one-time gains from the Unilever deal. The price-to-sales ratio of 2.61x is in line with peers. Overall, the valuation implies the market is pricing in significant execution risk, making it a potential value trap or opportunity depending on the deal's outcome.
MKC is a high-risk, high-reward investment. The forward P/E of 16.2x is below the industry average of 20x and the stock's historical range, suggesting potential value if the Unilever acquisition succeeds. However, the stock has declined 30.2% over the past year and is near its 52-week low, reflecting deep skepticism. The analyst consensus is neutral, with only 4 analysts covering the stock. For risk-tolerant investors with a 3-5 year horizon, MKC could be a good buy at current levels if they believe in the deal's long-term benefits. Conservative investors should wait for clearer signs of integration success, such as margin recovery above 14% and positive analyst upgrades.
MKC is better suited for long-term investment (3-5 years) due to the transformative nature of the Unilever acquisition, which will take time to realize synergies. The stock's beta of 0.626 indicates lower volatility than the market, but the 30.2% decline over the past year shows significant company-specific risk. Short-term trading is risky given the uncertainty around the deal's closing and integration. The dividend yield of 2.7% provides some income for long-term holders, but the payout ratio of 61.2% could be pressured if cash flow is diverted to debt repayment. A minimum holding period of 3 years is recommended to allow the acquisition to deliver results.